FDA Import Refusal 799-0120820-8/41/1 — Sanofi Aventis Us Inc
The FDA refused shipment 799-0120820-8/41/1 from Sanofi Aventis Us Inc (United States) on Apr 10, 2024. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal details
- Date
- Apr 10, 2024
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY17 INSULIN (INJ) (ANTI-DIABETIC)
- Charges
- 75